SCHEMBL5582019

SCHEMBL5582019

CC[C@H](C)[C@H](N)C(=O)Nc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.59
MEN1 O00255 7/20 0.59
MAPT P10636 6/20 0.59
LMNA P02545 4/20 0.59
ALDH1A1 P00352 4/20 0.59
NPSR1 Q6W5P4 1/20 0.59
POLB P06746 1/20 0.52
GAA P10253 1/20 0.51
DPP7 Q9UHL4 1/20 0.50
CIT O14578 1/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA7 P43166 2/20 0.48
CA14 Q9ULX7 2/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
HTT P42858 3/20 0.47
HPGD P15428 1/20 0.47
GLA P06280 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27676029 0.85 KMT2A (0.57) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL5303809 0.85 KMT2A (0.57) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL30631607 0.84 KMT2A (0.56) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL30686007 0.83 MEN1 (0.50) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL987822 0.82 KMT2A (0.61) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL9259881 0.82 KMT2A (0.61) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL10914836 0.82 KMT2A (0.61) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL3667726 0.81 CIT (0.53) KMT2AMEN1MAPTALDH1A1GAA
Hydrochloric Acid SCHEMBL1895198 0.81 KMT2A (0.59) KMT2AMEN1MAPTLMNAALDH1A1
SCHEMBL29111760 0.81 KMT2A (0.62) KMT2AMEN1MAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070059758-A1 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding THE GOVERNMENT OF THE USA OF AMERICA, REP. BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2007-03-15 US claimed
US-20030215820-A1 Interleukins; aminopeptidases; blot analysis; drug screening GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2003-11-20 US claimed
US-6303360-B1 CULTURING SPHINGOMONAS; MOLECULAR HYBRIDIZATION; GENETIC ENGINEERING; HYDROLYZES ANILIDES OF ALANINE, GLYCINE, LEUCINE, GLUTAMIC ACID, ASPARTIC ACID, LYSINE, ISOLEUCINE, AND VALINE NOVOZYMES BIOTECH, INC, 2001-10-16 US claimed
WO-2001064856-A2 REGULATORS OF TYPE-1 TUMOR NECROSIS FACTOR RECEPTOR AND OTHER CYTOKINE RECEPTOR SHEDDING THE GOVERNMENT OF THE UNITED STATES OF AMERICA, A S REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEA LTH AND HUMAN SERVICES (US) 2001-09-07 WO claimed
US-6184020-B1 AMINO ACID AND NUCLEOTIDE SEQUENCE; FOR PRODUCTION OF PROTEIN HYDROLYSATES USED AS FLAVORINGS IN FOODS NOVO NORDISK BIOTECH, INC. 2001-02-06 US claimed
CN-122038358-A Aminopeptidase APs8-A297V, aminopeptidase APs8-A599V and application thereof 中国海洋大学 2026-05-15 CN disclosed
EP-4596689-A1 ENZYME AGENT AND USE THEREOF Amano Enzyme Inc. (JP) 2025-08-06 EP disclosed
EP-4594335-A1 COMPOUND - DIAGNOSTIC MARKER FOR OVARIAN CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF OVARIAN CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF OVARIAN CANCER Urteste S.A. (PL) 2025-08-06 EP disclosed
CN-120092086-A Enzyme agent and application thereof 天野酶制品株式会社 2025-06-03 CN disclosed
WO-2024072241-A1 COMPOUND - DIAGNOSTIC MARKER FOR OVARIAN CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF OVARIAN CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF OVARIAN CANCER URTESTE S.A. (PL) 2024-04-04 WO disclosed
WO-2024071388-A1 ENZYME AGENT AND USE THEREOF 天野エンザイム株式会社 2024-04-04 WO disclosed
US-11946079-B2 Method for producing a protein hydrolysate using an endopeptidase and a carboxypeptidase NOVOZYMES A/S (DK) 2024-04-02 US disclosed
US-20220127592-A1 POLYPEPTIDE, USE AND METHOD FOR HYDROLYSING PROTEIN NOVOZYMES A/S (DK) 2022-04-28 US disclosed
US-20070059758-A1 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding THE GOVERNMENT OF THE USA OF AMERICA, REP. BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2007-03-15 US disclosed
US-7135303-B2 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2006-11-14 US disclosed
US-20030215820-A1 Interleukins; aminopeptidases; blot analysis; drug screening GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2003-11-20 US disclosed
WO-2001064856-A2 REGULATORS OF TYPE-1 TUMOR NECROSIS FACTOR RECEPTOR AND OTHER CYTOKINE RECEPTOR SHEDDING THE GOVERNMENT OF THE UNITED STATES OF AMERICA, A S REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEA LTH AND HUMAN SERVICES (US) 2001-09-07 WO disclosed